Alentis Therapeutics is a company that discovers and develops medications to treat liver diseases such as liver fibrosis, cirrhosis, and cancer. The company develops platform technologies and monoclonal antibodies. Its platform allows for the efficient discovery of compounds and targets that are relevant in the pathology of late-stage liver diseases.